These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16339202)

  • 1. Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice.
    Shearman LP; Wang SP; Helmling S; Stribling DS; Mazur P; Ge L; Wang L; Klussmann S; Macintyre DE; Howard AD; Strack AM
    Endocrinology; 2006 Mar; 147(3):1517-26. PubMed ID: 16339202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats.
    Kobelt P; Helmling S; Stengel A; Wlotzka B; Andresen V; Klapp BF; Wiedenmann B; Klussmann S; Mönnikes H
    Gut; 2006 Jun; 55(6):788-92. PubMed ID: 15994217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer.
    Helmling S; Maasch C; Eulberg D; Buchner K; Schröder W; Lange C; Vonhoff S; Wlotzka B; Tschöp MH; Rosewicz S; Klussmann S
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13174-9. PubMed ID: 15329412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-ghrelin Spiegelmer NOX-B11-3 blocks ghrelin- but not fasting-induced neuronal activation in the hypothalamic arcuate nucleus.
    Becskei C; Bilik KU; Klussmann S; Jarosch F; Lutz TA; Riediger T
    J Neuroendocrinol; 2008 Jan; 20(1):85-92. PubMed ID: 18081556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain.
    Halem HA; Taylor JE; Dong JZ; Shen Y; Datta R; Abizaid A; Diano S; Horvath TL; Culler MD
    Neuroendocrinology; 2005; 81(5):339-49. PubMed ID: 16210868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice.
    Lu SC; Xu J; Chinookoswong N; Liu S; Steavenson S; Gegg C; Brankow D; Lindberg R; Véniant M; Gu W
    Mol Pharmacol; 2009 Apr; 75(4):901-7. PubMed ID: 19129426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor.
    Toshinai K; Yamaguchi H; Sun Y; Smith RG; Yamanaka A; Sakurai T; Date Y; Mondal MS; Shimbara T; Kawagoe T; Murakami N; Miyazato M; Kangawa K; Nakazato M
    Endocrinology; 2006 May; 147(5):2306-14. PubMed ID: 16484324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
    Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.
    Bush EN; Shapiro R; Brune ME; Knourek-Segel VE; Droz BA; Fey T; Lin E; Jacobson PB
    Endocrine; 2006 Apr; 29(2):375-81. PubMed ID: 16785615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of ghrelin protects against early-onset obesity.
    Wortley KE; del Rincon JP; Murray JD; Garcia K; Iida K; Thorner MO; Sleeman MW
    J Clin Invest; 2005 Dec; 115(12):3573-8. PubMed ID: 16322795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes.
    Caminos JE; Gualillo O; Lago F; Otero M; Blanco M; Gallego R; Garcia-Caballero T; Goldring MB; Casanueva FF; Gomez-Reino JJ; Dieguez C
    Endocrinology; 2005 Mar; 146(3):1285-92. PubMed ID: 15576457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
    Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
    Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking ghrelin receptors resist the development of diet-induced obesity.
    Zigman JM; Nakano Y; Coppari R; Balthasar N; Marcus JN; Lee CE; Jones JE; Deysher AE; Waxman AR; White RD; Williams TD; Lachey JL; Seeley RJ; Lowell BB; Elmquist JK
    J Clin Invest; 2005 Dec; 115(12):3564-72. PubMed ID: 16322794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity.
    Longo KA; Govek EK; Nolan A; McDonagh T; Charoenthongtrakul S; Giuliana DJ; Morgan K; Hixon J; Zhou C; Kelder B; Kopchick JJ; Saunders JO; Navia MA; Curtis R; DiStefano PS; Geddes BJ
    J Pharmacol Exp Ther; 2011 Oct; 339(1):115-24. PubMed ID: 21775475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats.
    Tamura H; Kamegai J; Shimizu T; Ishii S; Sugihara H; Oikawa S
    Endocrinology; 2002 Sep; 143(9):3268-75. PubMed ID: 12193538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trp3, Arg5]-ghrelin(1-5) stimulates growth hormone secretion and food intake via growth hormone secretagogue (GHS) receptor.
    Ohinata K; Kobayashi K; Yoshikawa M
    Peptides; 2006 Jul; 27(7):1632-7. PubMed ID: 16530883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss.
    Perreault M; Istrate N; Wang L; Nichols AJ; Tozzo E; Stricker-Krongrad A
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):879-85. PubMed ID: 15111983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.